Catalyst Wire Dossier Catalyst Wire Dossier

Tetravalent dengue virus vaccine (investigational, admixtures)

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tetravalent dengue virus vaccine (investigational, admixtures), covering 2015-08-20 to 2015-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine [Phase 1]

See pricing